GANDOLFO, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 3.044
NA - Nord America 3.001
AS - Asia 1.609
SA - Sud America 300
AF - Africa 114
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.075
Nazione #
US - Stati Uniti d'America 2.945
RU - Federazione Russa 735
IT - Italia 580
SG - Singapore 526
IE - Irlanda 495
GB - Regno Unito 399
CN - Cina 362
VN - Vietnam 292
BR - Brasile 237
SE - Svezia 182
DE - Germania 161
FR - Francia 146
HK - Hong Kong 139
FI - Finlandia 110
IN - India 64
UA - Ucraina 64
ZA - Sudafrica 58
KR - Corea 52
BD - Bangladesh 36
PL - Polonia 33
ES - Italia 29
NL - Olanda 27
CA - Canada 25
MX - Messico 20
TR - Turchia 20
BE - Belgio 19
PK - Pakistan 16
AR - Argentina 15
CO - Colombia 14
IQ - Iraq 14
JP - Giappone 14
NG - Nigeria 13
AT - Austria 12
CI - Costa d'Avorio 11
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
IM - Isola di Man 9
CZ - Repubblica Ceca 8
ID - Indonesia 8
EC - Ecuador 7
MA - Marocco 7
CL - Cile 6
EG - Egitto 6
PE - Perù 6
VE - Venezuela 6
IL - Israele 5
KE - Kenya 5
TN - Tunisia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
DZ - Algeria 4
IR - Iran 4
LT - Lituania 4
MT - Malta 4
PT - Portogallo 4
PY - Paraguay 4
UY - Uruguay 4
CH - Svizzera 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PW - Palau 1
Totale 8.070
Città #
Dublin 480
Singapore 325
Dallas 323
Southend 308
Ashburn 251
Chandler 218
Fairfield 204
Moscow 204
Santa Clara 180
San Jose 166
Siena 164
Hong Kong 128
Beijing 105
Wilmington 91
Ho Chi Minh City 81
New York 77
Houston 76
Ann Arbor 75
Woodbridge 74
Council Bluffs 73
Cambridge 71
Los Angeles 71
Milan 70
Seattle 69
Princeton 68
Helsinki 67
Hanoi 62
The Dalles 59
Munich 58
Jacksonville 52
Seoul 50
Lauterbourg 48
Hefei 46
Johannesburg 46
Rome 43
Florence 35
Warsaw 31
Fremont 27
Dong Ket 25
São Paulo 25
Menlo Park 24
Buffalo 21
Da Nang 20
Frankfurt am Main 19
Shanghai 19
San Mateo 17
Turku 17
Brussels 16
Atlanta 14
Boardman 14
Chennai 14
Montreal 14
Málaga 14
San Diego 14
Haiphong 13
London 13
Nanjing 13
Redondo Beach 13
Tokyo 13
Abuja 12
Chicago 12
Lappeenranta 12
Nuremberg 12
Abidjan 11
Lancaster 11
Orem 11
Columbus 10
Düsseldorf 10
Portsmouth 10
Dearborn 9
Denver 9
Falls Church 9
Boston 8
Douglas 8
Izmir 8
Phoenix 8
Poplar 8
Rio de Janeiro 8
Bengaluru 7
Biên Hòa 7
Karlsruhe 7
Messina 7
Shenyang 7
Baghdad 6
Dubai 6
Espoo 6
Hải Dương 6
Norwalk 6
Stockholm 6
Toronto 6
Vienna 6
Washington 6
Ankara 5
Brooklyn 5
Dhaka 5
Falkenstein 5
Guangzhou 5
Istanbul 5
Jeddah 5
Madrid 5
Totale 5.243
Nome #
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 379
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 335
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 322
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 286
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 280
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 272
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 266
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 258
Host-pathogen interaction: study of Toscana virus 252
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 247
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 224
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 224
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 217
Identification of a neutralizing epitope on tosv gn glycoprotein 215
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 212
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 202
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 199
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 189
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 184
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 184
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 181
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 179
Comparative performance of a new sars-cov-2 rapid detection system 175
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 173
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 172
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 171
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 169
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 168
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 166
How long can SARS-CoV-2 persist in human corpses? 164
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 161
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 158
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 158
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 155
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 146
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified? 141
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix 118
Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay 115
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 114
null 103
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 103
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 94
Totale 8.231
Categoria #
all - tutte 27.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/2022529 34 33 24 39 23 27 21 16 99 45 57 111
2022/2023758 42 92 98 80 75 154 18 74 59 25 25 16
2023/2024862 24 51 70 47 35 212 307 24 7 14 16 55
2024/20251.440 57 61 158 94 163 98 94 94 160 80 157 224
2025/20263.224 228 383 282 460 733 139 450 86 129 209 87 38
Totale 8.231